A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction
European Journal of Heart Failure May 11, 2018
Popovic D, et al. - Researchers tested their premise that a flattening oxygen consumption (VO2) trajectory is helpful in phenotyping disease severity and prognosis in heart failure (HF) with either reduced (HFrEF), mid-range (HFmrEF) or preserved (HFpEF) ejection fraction. A flattening VO2 trajectory was found to be a probable novel and robust predictor of events in HF with any ejection fraction. This oxygen pattern might suggest a real-time decrease in pulmonary blood flow to the left heart, given the association of right-sided cardiac dysfunction with pulmonary hypertension.
Methods
- This study included 319 HF patients (198 HFrEF, 80 HFmrEF, and 41 HFpEF) who underwent CPET.
- A flattening VO2 trajectory was tracked and defined as an inflection of VO2 linearity as a function of work rate with a second slope downward inflection >35% extent of the first one.
- Researchers determined peak VO2, the minute ventilation/carbon dioxide production (VE/VCO2) slope, and the presence of exercise oscillatory ventilation (EOV).
- Echocardiography was used to measure pulmonary artery systolic pressure (PASP) and tricuspid annular plane systolic excursion (TAPSE).
- The combination of all-cause death, heart transplantation and left ventricular assist device implantation was primary outcome, and secondary outcome included primary outcome, plus hospitalization for cardiac reasons.
Results
- In 92 patients (28.8%), the occurrence of a flattening VO2 was detected.
- At rest, significantly higher PASP and significantly lower TAPSE were detected (P < 0.001).
- Data showed that, in the multivariate model including peak VO2, VE/VCO2 slope, EOV and VO2 trajectory, a flattening VO2 trajectory and EOV were retained in the regression for primary (X2 = 35.78, and 36.36, respectively; P < 0.001) and secondary (X2 = 12.45 and 47.91, respectively; P < 0.001) outcomes.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries